Deep Vein Thrombosis (DVT) Treatment: Anticoagulants, Compression, and Interventional Options

Cornerstone: Anticoagulation

DOACs preferred for most (no monitoring, fewer interactions, similar efficacy/safety). Duration: 3 months (provoked), 6–12 months or indefinite (unprovoked, recurrent, cancer).

Adjunctive Measures

  • Compression stockings: 20–30 mmHg, knee-high; reduce post-thrombotic syndrome (PTS) risk. Start early if tolerated.
  • Elevation: Leg above heart when sitting/lying.
  • Early ambulation: Not contraindicated; improves symptoms.
  • Analgesia: NSAIDs (caution with anticoagulants), acetaminophen; avoid aspirin unless indicated.

Interventional / Surgical

  • IVC filter: Only if anticoagulation contraindicated (active bleed, recent surgery) + acute proximal DVT/PE. Retrievable preferred; remove when safe.
  • Catheter-directed thrombolysis (CDT) / pharmacomechanical thrombectomy: Selected iliofemoral DVT <14 days, low bleed risk, good functional status — to prevent PTS.
  • Venous stenting: For chronic obstructive lesions (May-Thurner).
  • Surgical thrombectomy: Rare; phlegmasia cerulea dolens, failed CDT.

Follow-Up

  • Assess bleeding risk (HAS-BLED), renal function, adherence.
  • Evaluate for PTS (Villalta scale) at 3–6 months.
  • Cancer screening if unprovoked DVT >40 (per guidelines).

Blood Disorders - Related Articles

Health Sciences © https://www.222health.com

Drug ClassExamplesMonitoring
Direct Oral Anticoagulants (DOACs)Apixaban, Rivaroxaban, Dabigatran, EdoxabanRenal function; no routine INR
Vitamin K AntagonistWarfarinINR target 2.0–3.0
Low Molecular Weight HeparinEnoxaparin, DalteparinAnti-Xa (renal impairment, extremes weight)
Unfractionated HeparinIV infusionaPTT or anti-Xa